JNJ
Price
$154.53
Change
-$0.39 (-0.25%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
380.22B
86 days until earnings call
NVS
Price
$112.17
Change
+$1.00 (+0.90%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
197.93B
2 days until earnings call
Ad is loading...

JNJ vs NVS

Header iconJNJ vs NVS Comparison
Open Charts JNJ vs NVSBanner chart's image
Johnson & Johnson
Price$154.53
Change-$0.39 (-0.25%)
Volume$45.36K
Capitalization380.22B
Novartis AG
Price$112.17
Change+$1.00 (+0.90%)
Volume$15.31K
Capitalization197.93B
JNJ vs NVS Comparison Chart
Loading...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JNJ vs. NVS commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNJ is a Buy and NVS is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (JNJ: $154.93 vs. NVS: $111.17)
Brand notoriety: JNJ: Notable vs. NVS: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: JNJ: 80% vs. NVS: 61%
Market capitalization -- JNJ: $380.22B vs. NVS: $197.93B
JNJ [@Pharmaceuticals: Major] is valued at $380.22B. NVS’s [@Pharmaceuticals: Major] market capitalization is $197.93B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JNJ’s FA Score shows that 2 FA rating(s) are green whileNVS’s FA Score has 2 green FA rating(s).

  • JNJ’s FA Score: 2 green, 3 red.
  • NVS’s FA Score: 2 green, 3 red.
According to our system of comparison, JNJ is a better buy in the long-term than NVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JNJ’s TA Score shows that 5 TA indicator(s) are bullish while NVS’s TA Score has 7 bullish TA indicator(s).

  • JNJ’s TA Score: 5 bullish, 5 bearish.
  • NVS’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, NVS is a better buy in the short-term than JNJ.

Price Growth

JNJ (@Pharmaceuticals: Major) experienced а -1.61% price change this week, while NVS (@Pharmaceuticals: Major) price change was +0.28% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.23%. For the same industry, the average monthly price growth was -2.27%, and the average quarterly price growth was -8.41%.

Reported Earning Dates

JNJ is expected to report earnings on Jul 22, 2025.

NVS is expected to report earnings on Jul 17, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+2.23% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($380B) has a higher market cap than NVS($198B). JNJ has higher P/E ratio than NVS: JNJ (30.34) vs NVS (23.38). NVS YTD gains are higher at: 18.356 vs. JNJ (7.987). JNJ has higher annual earnings (EBITDA): 23.3B vs. NVS (18.3B). JNJ has more cash in the bank: 22.9B vs. NVS (14B). NVS has less debt than JNJ: NVS (26.3B) vs JNJ (29.3B). JNJ has higher revenues than NVS: JNJ (85.2B) vs NVS (46.7B).
JNJNVSJNJ / NVS
Capitalization380B198B192%
EBITDA23.3B18.3B127%
Gain YTD7.98718.35644%
P/E Ratio30.3423.38130%
Revenue85.2B46.7B182%
Total Cash22.9B14B164%
Total Debt29.3B26.3B111%
FUNDAMENTALS RATINGS
JNJ vs NVS: Fundamental Ratings
JNJ
NVS
OUTLOOK RATING
1..100
7367
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
16
Undervalued
PROFIT vs RISK RATING
1..100
2313
SMR RATING
1..100
4537
PRICE GROWTH RATING
1..100
5045
P/E GROWTH RATING
1..100
6067
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVS's Valuation (16) in the Pharmaceuticals Major industry is in the same range as JNJ (18). This means that NVS’s stock grew similarly to JNJ’s over the last 12 months.

NVS's Profit vs Risk Rating (13) in the Pharmaceuticals Major industry is in the same range as JNJ (23). This means that NVS’s stock grew similarly to JNJ’s over the last 12 months.

NVS's SMR Rating (37) in the Pharmaceuticals Major industry is in the same range as JNJ (45). This means that NVS’s stock grew similarly to JNJ’s over the last 12 months.

NVS's Price Growth Rating (45) in the Pharmaceuticals Major industry is in the same range as JNJ (50). This means that NVS’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's P/E Growth Rating (60) in the Pharmaceuticals Major industry is in the same range as NVS (67). This means that JNJ’s stock grew similarly to NVS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
JNJNVS
RSI
ODDS (%)
Bullish Trend 6 days ago
49%
Bullish Trend 6 days ago
48%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
44%
Bearish Trend 6 days ago
37%
Momentum
ODDS (%)
Bullish Trend 6 days ago
45%
Bullish Trend 6 days ago
46%
MACD
ODDS (%)
Bullish Trend 6 days ago
43%
Bullish Trend 6 days ago
56%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
42%
Bullish Trend 6 days ago
49%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
42%
Bearish Trend 6 days ago
38%
Advances
ODDS (%)
Bullish Trend 11 days ago
40%
Bullish Trend 13 days ago
48%
Declines
ODDS (%)
Bearish Trend 20 days ago
42%
Bearish Trend 20 days ago
43%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
48%
Bullish Trend 6 days ago
50%
Aroon
ODDS (%)
Bearish Trend 6 days ago
32%
Bullish Trend 6 days ago
38%
View a ticker or compare two or three
Ad is loading...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA259.518.77
+3.50%
Tesla
SPY546.6911.27
+2.10%
SPDR® S&P 500® ETF
AAPL208.373.77
+1.84%
Apple
BTC.X93943.800000244.687500
+0.26%
Bitcoin cryptocurrency
GME27.08-0.04
-0.15%
GameStop Corp

JNJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with PFE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
-0.29%
PFE - JNJ
54%
Loosely correlated
+1.74%
NVS - JNJ
48%
Loosely correlated
+0.94%
GSK - JNJ
46%
Loosely correlated
+1.27%
ABBV - JNJ
41%
Loosely correlated
+1.88%
GILD - JNJ
41%
Loosely correlated
-0.22%
More

NVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVS has been loosely correlated with GSK. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if NVS jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVS
1D Price
Change %
NVS100%
+0.94%
GSK - NVS
58%
Loosely correlated
+1.27%
AZN - NVS
58%
Loosely correlated
+1.52%
JNJ - NVS
48%
Loosely correlated
-0.29%
PFE - NVS
46%
Loosely correlated
+1.74%
ABBV - NVS
43%
Loosely correlated
+1.88%
More